| Analysis at 2/19/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 3.97% | 25.45% | 46.47% | 56.97% |
| Analysis at 2/19/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 23.99% | 17.89% | 16.99% |
| Negative volatility | 13.28% | 10.15% | 9.97% |
| Sharpe | 0.78 | 0.56 | 0.50 |
| Sortino | 1.42 | 0.98 | 0.85 |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Candriam Eq. L Biotechnology R Cap EUR | 5.54% | 5.80% | 4.44% | 10.37% | 23.25% | 3.97% | |
| Equity Sector - Biotechnology | 16.35% | 15.35% | 0.35% | 6.70% | 8.38% | 4.40% | |